Drug Type ASO |
Synonyms SQY 51, SQY51 |
Target |
Mechanism dystrophin inhibitors(Dystrophin inhibitors), Dystrophin expression stimulants, RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Phase 2 | FR | 26 Apr 2023 |